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Abstract
Introduction: With a rising incidence of severe obesity in developed nations, heart failure, a well-
recognised co-morbidity, is becoming more common.
Case presentation: We describe two recent patients encountered, a 64 year old and a 42 year
old, who are both severely obese and presented with fluid retention of approximately 40 kilograms.
Assessment revealed that the explanation of the gross clinical features were relatively subtle
cardiac abnormalities. These cases illustrate how fluid retention in severe obesity can differ from
that seen in 'traditional' heart failure in terms of clinical assessment and management.
Conclusion: Severe obesity can result in insidious fluid retention, which can be easily overlooked
until large volumes of fluid have accumulated. Cardiac abnormalities are usually found in these
patients, but may be relatively subtle, leading to current debate in the definition and classification
of heart failure. These scenarios are increasingly being encountered in clinical practice. Recognition,
assessment and treatment of the 'clinical syndrome of heart failure' in severe obesity is often
difficult.
Introduction
The commonest causes of heart failure are ischaemic heart
disease, hypertension, diabetes mellitus, and left ventricu-
lar hypertrophy [1]. The management of cardiac failure
has evolved to cope with these 'traditional' aetiologies.
However, as severe obesity becomes more frequent, so
does heart failure, a well-recognised co-morbidity. Unfor-
tunately, awareness of the problem is lagging behind the
epidemiology; the British National Institute for Health
and Clinical Excellence (NICE) guidelines do not high-
light obesity as a potential cause or a contributory factor
in heart failure [2]. In addition, the conventional diag-
noses of heart failure based on echocardiological findings
do not cover the majority of patients with symptoms of
cardiac dysfunction. There is currently much debate as to
how to define and classify heart failure, with new concepts
arising such as 'diastolic heart failure', 'heart failure with
normal ejection fraction (HFNEF)', 'acute heart failure
syndrome' and 'clinical syndrome of heart failure' [3-5].
Mostly, such diagnostic difficulties occur in elderly
patients with multiple co-morbidities, but increasingly
severe obesity is another important factor.
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We report two recent cases illustrating an increasingly
common scenario.
Case Presentation
Case 1
A 64 year old Caucasian lady was admitted as an emer-
gency with worsening dyspnoea and oedema. During the
three weeks prior to admission she had decreasing exer-
cise tolerance, struggling even to transfer from her bed due
to a combination of breathlessness, muscle aches and the
sheer weight of her legs. During the preceding nine
months, she had three admissions for cellulitis of her
swollen legs. Review of the records revealed progressive
weight gain of 36 kg over this time.
Her past medical history included type 2 diabetes melli-
tus, hypertension, and atrial fibrillation, all of which had
been controlled on medication for at least 12 months. She
also had non-alcoholic steatohepatitis and smoked 5 cig-
arettes daily. She never had rheumatic fever, heart valvular
problems or any cardiovascular events. Her medications
were glibenclamide, metformin, co-amilofruse, enalapril,
simvastatin, and digoxin.
On examination, she weighed 160.8 kg (equivalent to
body mass index (BMI) 60.5 kg/m2). There was marked
pitting oedema involving both legs, abdomen and chest
wall with patches of cellulitis within the oedematous
areas (Figure 1). She was haemodynamically stable with a
normal venous pressure, impalpable apex beat and nor-
mal cardiac auscultation. Chest examination was normal
apart from a few bilateral basal crackles. The remaining
examination was unremarkable.
Electrocardiogram revealed atrial fibrillation (80 beats/
minute) and small QRS complexes. Blood tests were unre-
markable. She had evidence of mild proteinuria but no
clinical nephrotic syndrome and her renal function was
normal. Chest radiography revealed cardiomegaly with
bulky hila due to vascular changes. Transthoracic echocar-
diography showed a normal left ventricular size with an
ejection fraction of 65%, bi-atrial enlargement and a
dilated right ventricle with good function. Investigations
gave no evidence of pulmonary embolus, ascites, sleep
disordered breathing or other cause of cardiomyopathy.
She was treated with intravenous furosemide initially and
later with metolazone and spironolactone. Her weight
reduced by 35.6 kg over 42 days and by 41.8 kg when
reviewed in clinic. The patient was not on a strict diet dur-
ing this period.
Case 2
A 42 year old Caucasian lady was admitted from an obes-
ity clinic. She had been referred by her general practitioner
because of more than 35 kg weight gain over ten months.
During this period, she had developed swelling in legs
and abdomen but despite furosemide (80 mg daily), the
oedema had progressed to render her bedbound.
She had been obese since childhood and depressed
recently, but had no other significant medical history. She
never had rheumatic fever, diabetes, hypertension, valvu-
lar heart problems or any vascular events. Her medica-
tions on presentation were furosemide and sertraline. She
did not smoke and drank approximately eight units of
alcohol a week.
On examination, she weighed 185.1 kg (equivalent BMI
66 kg/m2). There was pitting oedema extending up to her
abdomen. Her pulse was 100 beats/minute irregularly
irregular. Blood pressure was 155/85 mmHg and jugular
venous pressure raised to her ear lobes. The apex beat was
impalpable. Cardiac auscultation and chest examination
were normal. Besides a large paraumbilical hernia, the
remaining examination was unremarkable.
Electrocardiogram revealed fast atrial fibrillation and
poor R-wave progression in the chest leads. Chest radio-
graph showed cardiomegaly but normal lung fields
(allowing for the quality of the film).
Photograph showing marked pitting oedema above the  umbilicus with areas of cellulitis Figure 1
Photograph showing marked pitting oedema above 
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Transthoracic echocardiography showed normal left ven-
tricular size with mild concentric hypertrophy and good
systolic function. Right ventricle and both atria were all
dilated. A myocardial perfusion scan confirmed ejection
fraction of 56% with no evidence of ischaemia. Further
tests gave no evidence of pulmonary embolus, sleep disor-
dered breathing or other cause of cardiomyopathy.
During two months treatment with digoxin, warfarin,
ramipril and furosemide 250 mg daily, her weight
declined by 40.1 kg to 145.0 kg. She was not a restrictive
diet during this period. She later underwent successful
bariatric surgery and hernia repair.
Discussion
Over 2% of the adult population in the United Kingdom
is morbidly obese and this proportion is increasing. Obes-
ity-related mortality and morbidity are rising. The associ-
ation between obesity and heart failure is well recognised
[6]. Obesity increases many of the established risks for
heart failure including hypertension, type 2 diabetes mel-
litus, and dyslipidaemia. Several mechanisms are recog-
nised for a 'direct' effect of obesity per se on heart failure.
Indeed, cardiac disease remains the commonest cause of
premature death in severe obesity with most deaths occur-
ring below the age of 50 [7]. Both these ladies had severe
fluid retention with no other cause apparent apart from
relatively mild cardiac abnormalities.
Severe obesity changes the clinical problem of fluid reten-
tion. In our cases the only abnormalities identified were
cardiac. Heart failure in severe obesity can differ from 'tra-
ditional' heart failure in several aspects.
Firstly, the extent of fluid retention is relatively hidden by
the sheer physical mass of the patient (as seen in both our
patients) and by the gradual and insidious accumulation
of fluid. Most severely obese patients have some degree of
oedema and display nutrition-related weight changes, so
it is difficult to recognise worsening oedema.
Secondly, in severe obesity there can be multiple contrib-
utors to the dyspnoea and oedema. Hypertension, diabe-
tes, sleep disordered breathing, 'obesity-related asthma',
non-alcoholic fatty liver, focal-segmental glomerulo-scle-
rosis, low physical fitness levels, thromboembolic disease,
lymphoedema, and vitamin deficiencies are all common
[8]. Obesity potentiates the sympathetic activation seen in
heart failure leading to renin-angiotensin-aldosterone axis
activation, resulting in further salt and fluid accumulation
[9].
Thirdly, cardiac evaluation of the severely obese patient is
technically difficult and interpretation controversial.
Severe obesity affects cardiac mass, morphology, and his-
tology [10]. The normal ejection fraction in both our
patients is a reflection of the relative insensitivity of this
index of cardiac function. In the absence of systolic abnor-
malities our patients do not satisfy some criteria for heart
failure. The mild echocardiological abnormalities in our
cases would allow a diagnosis of diastolic dysfunction or
HFNEF (heart failure with normal ejection fraction) both
more common in severely obese patients. Others would
take a more agnostic line and label this 'acute heart failure
syndrome' or 'clinical syndrome of heart failure' [4,5].
More sensitive techniques such as myocardial tissue Dop-
pler frequently reveal more subtle abnormalities, even in
asymptomatic obese patients [11]. Reliance on ejection
fraction as a means of diagnosing heart failure in obese
patients only detects a proportion of cases, whilst the
majority (like ours) would remain unrecognised. The rel-
atively subtle cardiac abnormalities in our patients may
have contributed to the slow and insidious accumulation
of fluid. Unfortunately, usual criteria for diagnosing and
grading diastolic dysfunction, such as Doppler measure-
ments of transmitral and pulmonary vein flow can have
poor diagnostic concordance and discriminatory value
[12]. Atrial fibrillation further reduces the sensitivity of
echocardiography. Gold standard left heart cathetherisa-
tion and evaluation of pressure-volume curves at rest and
during exercise are not feasible as an investigative tool for
the majority of severely obese patients [13]. Natriuretic
peptides (e.g. N-terminal proBNP) are elevated in severe
obesity per se even without heart failure and may also be
elevated in non-cardiac causes of fluid retention [14].
Treatment of heart failure in severe obesity is poorly stud-
ied as such patients are routinely excluded from drug tri-
als. Weight reduction reverses haemodynamic
abnormalities including left ventricular hypertrophy and
diastolic dysfunction in the obese [15]. However, for a
patient with 40 kg of fluid overload, one should not await
weight reduction from lifestyle changes or anti-obesity
drugs. Bariatric surgery is hazardous unless heart failure
has been recognised and treated. Appreciation of the large
amounts of oedema that can accumulate is important if
obese patients are not to be undertreated.
Conclusion
The profile of heart failure is changing. Our patients illus-
trate not uncommon scenarios. Severely obese patients
can insidiously gain considerable amounts of relatively
hidden fluid that can be overlooked until large volumes of
fluid have accumulated. Cardiac abnormalities are usually
found in such patients, but may be relatively subtle and
recognition, quantification, assessment and treatment can
be difficult.
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